Legislative Issues

Greenwood praises passage of pandemic influenza plan

Published in Vaccine Weekly, January 25th, 2006

Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), released the following statement on Congress' vote to pass President Bush's national strategy for pandemic influenza, as part of the U.S. Department of Defense appropriations bill:

"The implementation of the president's national strategy for pandemic influenza takes the first step on the path for the U.S. to develop a domestic vaccine industry that will substantially improve our national security and our health security. I applaud the president for his leadership." The legislation "provides critical resources to stockpile existing therapies and to accelerate the development of new,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2006-01-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry